A phase one trial of one of the world’s first multivariant COVID-19 Vaccine has been launched by US pharmaceutical company Gritstone, in collaboration with MFT.
Read more
A 70-year-old woman, forced to live with cough since her 40s, is ‘excited’ to be the first person in the world to receive a potential new cough treatment.
Read more
Manchester University NHS Foundation Trust is opening themselves up to a three-month reflective assessment of their delivery of race equality in health research.
Read more
People across Greater Manchester are being asked to play their part in helping vital research into new COVID-19 treatments.
Read more
The Chief Operating Officer of the NIHR Clinical Research Network (CRN) Greater Manchester has volunteered to take part in a COVID-19 booster vaccine study.
Read more
The exceptional contribution of three MFT colleagues to research and innovation has been recognised by the Manchester Academic Health Science Centre (MAHSC).
Read more
In her blog Dr Natasha Odell shares her research experience at NIHR Manchester Clinical Research Facility.
Read more
A young lupus patient is encouraging others to take part in research, after she volunteered for the NIHR Immune-Mediated Inflammatory Diseases (IMID) BioResource.
Read more
